NSE filing, NSE: SHANTHALA. Summary written from the filing by ALFA Finder's alert engine.
Shanthala FMCG Products Ltd: key numbers
- Share price
- ₹10.45
- Market cap
- ₹7.00 Cr
- Revenue (annual)
- ₹52.75 Cr
- Net profit (annual)
- ₹0.97 Cr
- P/E (TTM)
- 7.2×Sector 36.4×
- Promoter holding
- 62.13%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shanthala FMCG Products Ltd
All →Shanthala FMCG Products Board Meeting Outcome
The company's board meeting noted the final forensic audit report submitted by M/s. GuruJana Consulting LLP.
Shanthala FMCG Products Other Announcement
Shanthala FMCG received a one-month ROC extension to hold its FY2025-26 AGM under Section 96(1). The AGM was originally due by 30 September 2026.
Shanthala FMCG Products Other Announcement
Shanthala FMCG Products Limited has received approval from the Registrar of Companies to extend the deadline for holding its Annual General Meeting by one month.
Shanthala FMCG Products Other Announcement
Shanthala FMCG applied to the ROC for a three-month AGM extension due to ongoing forensic audit. FY 2025-26 financials await the audit report.
- Execution
- 3 months extension sought
Shanthala FMCG Products Legal & Regulatory
Shanthala FMCG informed the Exchange of Board comments regarding NSE penalties for non-compliance with Regulation 33. The company will remit the ₹0.02 Crore fine.
- Value
- ₹0.02 Cr
Shanthala FMCG Products Adverse Business Impact
Shanthala FMCG Products Limited announced the termination of its distributorship arrangement with Hindustan Unilever Limited. The board also reviewed an ongoing forensic audit and non-compliance notices.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.